, 18 , 569-585, doi: Hsu, T
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition
Pharmacological or genetic glutaminase regulation along with oxidative chemotherapy can help to improve the design of combination strategies that escalate the rate of therapeutic success in cancer patients
In comparison with the TAA group, the 25-mg/kg dose reduced MDA by 50.2% and increased GSH and SOD by 38.8% and 229.2%, respectively
Clinical Benefits: Supports cellular energy production via the Krebs cycle and mitochondrial function Assists in the metabolism of carbohydrates, fats, and proteins Supports peripheral and central nervous system function Provides antioxidant protection against oxidative stress Supports immune function and recovery from illness May help address fatigue, low mood, and cognitive difficulties This combination is often recommended as part of a broader treatment plan for patients with chronic fatigue, nutritional deficiencies, or those who are not responding adequately to oral supplementation alone